For both engagers, we detected an increase in apoptosis induction in C22orf46 knockout cells compared to a nt control (Fig 2E) in the same range as expected from the Her2-CD3 biAb (Fig 2A and D), verifying effects independent of the cancer antigen. This evidence concerns the gene ERBB2 and cancer.